3 news items
FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients
DVAX
14 May 24
for adults on hemodialysis.
The FDA has issued a Complete Response Letter stating that the application did not provide sufficient
Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.
DVAX
14 May 24
(Recombinant), Adjuvanted] regimen for adults on hemodialysis. The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL
Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates
DVAX
8 May 24
® adjuvant, which has demonstrated its ability to enhance the immune response with a favorable
- Prev
- 1
- Next